AsedaSciences, which developed the 3RnD toxicity intelligence platform for chemical risk assessment, has formed a strategic sales and marketing agreement with eMolecules, a provider of compound sourcing and scientific services
Via its Frontier Scientific division, eMolecules will provide integrated compound storage, preparation, aliquoting, quality control, and inventory services through the 3RnD platform.
The partnership will help to address one of the most critical steps in chemical research and development: ensuring that compounds entering analytical and biological testing are accurately identified, properly stored, correctly prepared, and quality controlled before experimental testing begins.
Improper storage, inaccurate preparation, degradation, contamination, and incorrect concentrations can alter biological responses, activate unintended cellular stress pathways, and lead to false conclusions, wasted resources, and incorrect development decisions.
Integrating Frontier Scientific into the 3RnD ecosystem enables researchers to gain access to professional compound management workflows that help ensure every study begins with the correct molecule, at the correct concentration and verified purity.
Brad Calvin, CEO of AsedaSciences, said, “High-quality biological data begins long before the first experiment is performed. Professional compound management is one of the most underappreciated determinants of experimental success. Even the most sophisticated New Approach Method or AI model cannot compensate for poor compound quality or preparation. Through our partnership with eMolecules, we are establishing a robust foundation that safeguards data quality from the very beginning of the R&D workflow.”
Frontier Scientific provides compound lifecycle management, including secure storage of powders and DMSO stocks, automated inventory tracking, expert solution preparation, aliquoting, analytical quality control and environmentally responsible compound disposal. These services help to minimise the burden on individual laboratories while reducing the risk of sample mix-ups, compound degradation, inventory loss and variability introduced through manual handling.
For organisations without dedicated compound management infrastructure, outsourcing these activities opens access to specialised expertise, validated workflows, and digital inventory management.
The integration represents another expansion of the growing portfolio of foundational Tier 1 services available through the 3RnD platform. Combined with capabilities such as compound procurement, physicochemical characterisation, and solubility profiling, professional compound management can help establish a starting point before compounds progress into downstream biological screening, New Approach Methods (NAMs), mechanistic assays, and AI-driven toxicity prediction.
Maintaining compound integrity is essential for modern NAMs, where subtle differences in compound identity or degradation products can influence cellular signalling pathways, stress responses, and mechanistic endpoints. Ensuring compounds remain chemically stable and accurately characterised can help preserve the integrity of the biological data generated, producing datasets suitable for AI and machine learning applications.
Rick Hammar, vice president of sales, Compound Management Services, eMolecules, said, “Our goal is to help scientists generate data they can trust. By combining our expertise in compound management with the 3RnD platform, researchers gain access to an integrated workflow that reduces operational complexity while improving confidence in every downstream experiment.”
In addition to improving experimental reproducibility, the partnership addresses common operational challenges faced by research organisations, including:
- Maintaining long-term compound stability under appropriate storage conditions.
- Accurate preparation of DMSO and assay-ready solutions.
- Prevention of sample loss, contamination and inventory errors.
- Analytical verification of compound identity, purity and degradation products.
- Digital inventory tracking and chain-of-custody management.
- Environmentally responsible disposal of expired or degraded compounds.
- Standardised workflows that improve reproducibility across research programs.
For AsedaSciences, the collaboration strengthens the company’s aim of creating a complete digital ecosystem to support safer, faster, and more reliable chemical R&D. Every integrated service in 3RnD is chosen to enhance the quality, reproducibility and predictive value of experimental data while helping researchers make better-informed decisions earlier in development.
The collaboration also broadens the reach of eMolecules’ compound management capabilities by making them accessible to pharmaceutical, biotechnology, chemical, and academic researchers using the 3RnD platform.
Both companies have a focus on accelerating the adoption of high-quality compound management practices alongside NAM, supporting more efficient chemical development while reducing unnecessary experimentation and improving confidence in downstream decision-making.
